First-line doxorubicin and high-dose ifosfamide (DHI) in advanced soft tissue sarcoma (STS) patients. A phase II study of the Spanish Group for Research on Sarcomas (GEIS)

被引：0
|
作者：
Lopez-Pousa, A [1 ]
Montalar, J [1 ]
Buesa, J [1 ]
Maurel, J [1 ]
Martin, J [1 ]
Cassinello, J [1 ]
Sevilla, I [1 ]
de las Penas, R [1 ]
Cruz, J [1 ]
Balana, C [1 ]
机构：
[1] Hosp Sant Pau, Spanish Grp Res Sarcomas, Barcelona, Spain
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
564P
引用
收藏
页码：117 / 117
页数：1
相关论文
共 50 条
  • [41] HIGH-DOSE DTIC IN ADVANCED SOFT-TISSUE SARCOMAS IN THE ADULT - A PHASE II STUDY OF THE EORTC SOFT-TISSUE AND BONE-SARCOMA-GROUP
    BUESA, JM
    MOURIDSEN, HT
    VANOOSTEROM, AT
    VERWEIJ, J
    WAGENER, T
    STEWARD, W
    POVEDA, A
    VESTLEV, PM
    THOMAS, D
    SYLVESTER, R
    ANNALS OF ONCOLOGY, 1991, 2 (04) : 307 - 309
  • [42] Immune-checkpoint genes as predictive biomarkers of trabectedin in advanced soft-tissue sarcoma (STS): A Spanish Group for Research on Sarcomas (GEIS) translational study.
    Silva Moura, David
    Hindi, Nadia
    Lopez-Alvarez, Maria
    Sanchez-Bustos, Paloma
    Carrasco-Garcia, Irene
    Santos-Fernandez, Paloma
    Martinez-Delgado, Paula
    Lacerenza, Serena
    Blanco-Alcaina, Elena
    Lucinio Mondaza-Hernandez, Jose
    Gutierrez, Antonio
    Maria Alvarez, Rosa
    Cordeiro, Magda
    De Sande Gonzalez, Luis Miguel
    Marquina, Gloria
    Maria Cano, Juana
    Cruz Jurado, Josefina
    Valverde Morales, Claudia Maria
    Martinez-Trufero, Javier
    Martin Broto, Javier
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [43] Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
    Garcia del Muro, Xavier
    de Alava, Enrique
    Artigas, Vicenc
    Bague, Silvia
    Brana, Alejandro
    Cubedo, Ricardo
    Cruz, Josefina
    Mulet-Margalef, Nuria
    Narvaez, Jose A.
    Martinez Tirado, Oscar
    Valverde, Claudia
    Verges, Ramona
    Vinals, Joan
    Martin-Broto, Javier
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2016, 77 (01) : 133 - 146
  • [44] Clinical practice guidelines for the diagnosis and treatment of patients with soft tissue sarcoma by the Spanish group for research in sarcomas (GEIS)
    Xavier Garcia del Muro
    Enrique de Alava
    Vicenç Artigas
    Silvia Bague
    Alejandro Braña
    Ricardo Cubedo
    Josefina Cruz
    Nuria Mulet-Margalef
    Jose A. Narvaez
    Oscar Martinez Tirado
    Claudia Valverde
    Ramona Verges
    Joan Viñals
    Javier Martin-Broto
    Cancer Chemotherapy and Pharmacology, 2016, 77 : 133 - 146
  • [45] Brostallicin versus doxorubicin as first-line chemotherapy in patients with advanced or metastatic soft tissue sarcoma: An European Organisation for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group randomised phase II and pharmacogenetic study
    Gelderblom, H.
    Blay, J. Y.
    Seddon, B. M.
    Leahy, M.
    Ray-Coquard, I.
    Sleijfer, S.
    Kerst, J. M.
    Rutkowski, P.
    Bauer, S.
    Ouali, M.
    Marreaud, S.
    van der Straaten, R. J. H. M.
    Guchelaar, H-J
    Weitman, S. D.
    Hogendoorn, P. C. W.
    Hohenberger, P.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 (02) : 388 - 396
  • [46] High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group
    Nielsen, OS
    Dombernowsky, P
    Mouridsen, H
    Crowther, D
    Verweij, J
    Buesa, J
    Steward, W
    Daugaard, S
    van Glabbeke, M
    Kirkpatrick, A
    Tursz, T
    BRITISH JOURNAL OF CANCER, 1998, 78 (12) : 1634 - 1639
  • [47] High-dose epirubicin is not an alternative to standard-dose doxorubicin in the treatment of advanced soft tissue sarcomas. A study of the EORTC soft tissue and bone sarcoma group
    OS Nielsen
    P Dombernowsky
    H Mouridsen
    D Crowther
    J Verweij
    J Buesa
    W Steward
    S Daugaard
    M van Glabbeke
    A Kirkpatrick
    T Tursz
    British Journal of Cancer, 1998, 78 : 1634 - 1639
  • [48] Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies
    Leyvraz, S.
    Herrmann, R.
    Guillou, L.
    Honegger, H. P.
    Christinat, A.
    Fey, M. F.
    Sessa, C.
    Wernli, M.
    Cerny, T.
    Dietrich, D.
    Pestalozzi, B.
    BRITISH JOURNAL OF CANCER, 2006, 95 (10) : 1342 - 1347
  • [49] Treatment of advanced soft-tissue sarcomas using a combined strategy of high-dose ifosfamide, high-dose doxorubicin and salvage therapies
    S Leyvraz
    R Herrmann
    L Guillou
    H P Honegger
    A Christinat
    M F Fey
    C Sessa
    M Wernli
    T Cerny
    D Dietrich
    B Pestalozzi
    British Journal of Cancer, 2006, 95 : 1342 - 1347
  • [50] Phase I multicenter study of combined high-dose ifosfamide and doxorubicin in the treatment of advanced sarcomas
    Leyvraz, S
    Bacchi, M
    Cerny, T
    Lissoni, A
    Sessa, C
    Bressoud, A
    Hermann, R
    ANNALS OF ONCOLOGY, 1998, 9 (08) : 877 - 884
12345